Latest news and insights on the pharmaceutical industry | Indian Pharma Post

Upcoming E-conference

No Record Found!!

Startup

SigTuple’s AI100 with Shonit receives USFDA 510(k) clearance
SigTuple’s AI100 with Shonit receives USFDA 510(k) clearance
DIC invests in US-based biotech startup
DIC invests in US-based biotech startup
LISSUN announces 2nd edition of its campaign -'#LISSUNToYourMind'
LISSUN announces 2nd edition of its campaign -'#LISSUNToYourMind'
View More

Digitization

BrainSpec receives FDA clearance to begin using AI-backed solution for non-invasive brain chemistry measurement
BrainSpec receives FDA clearance to begin using AI-backed solution for non-invasive brain chemistry measurement
LTTS, NVIDIA to unveil Gen AI and software defined architecture for medical devices
LTTS, NVIDIA to unveil Gen AI and software defined architecture for medical devices
AstraZeneca to leverage its capabilities to boost US renewable natural gas productivity
AstraZeneca to leverage its capabilities to boost US renewable natural gas productivity
View More

Latest Stories

Tele-MANAS Cell established at Armed Forces Medical College, Pune

AIIA initiates training programme on latent tuberculosis infections

Developing entrepreneurship in Ayush Sector is a priority area: Ayush Minister

Venus Remedies granted market authorizations in Saudi Arabia and Philippines

AstraZeneca Pharma appoints Venkat Natarajan as Lead - Market Access

White Papers

Chasing Consistency: Centralizing operations data is the key to optimizing chemicals plants

Implementing a digital transformation in chemical operations to maximize profitability

The complexity of compliance

The Sprint to the Summit: Unlocking Lab Efficiency through Digital Transformation

The guiding role of fluidized and spouted bed technologies in particle building processes

Opinion
Defending Public Health: Strategies to safeguard pharmaceutical quality: Raheel Shah, Business Development Director, BDR Pharmaceuticals
Defending Public Health: Strategies to safeguard pharmaceutical quality: Raheel Shah, Business Development Director, BDR Pharmaceuticals
Advanced Treatments for Brain Tumors: Secure Procedures Available
Advanced Treatments for Brain Tumors: Secure Procedures Available

Interviews
Capex commitment likely to be in the range of Rs. 200-300 Cr: Dr. R. Ananthanarayanan, CEO, Sajjan India
Capex commitment likely to be in the range of Rs. 200-300 Cr: Dr. R. Ananthanarayanan, CEO, Sajjan India
Dr. R. Ananthanarayanan CEO, Sajjan India
Our focus is on organic expansion and building our own plants...: Dr. Aman Desai, Promoter and Whole Time Director, Aether Industries
Our focus is on organic expansion and building our own plants...: Dr. Aman Desai, Promoter and Whole Time Director, Aether Industries
Dr. Aman Desai Promoter and Whole Time Director, Aether Industries
We have consistently expanded our business in India: Vinod Paremal, President & MD, Evonik, India Region
We have consistently expanded our business in India: Vinod Paremal, President & MD, Evonik, India Region
Vinod Paremal President & MD, Evonik, India Region

Packaging